The story of Viagra and its parent , copyright, presents a tangled picture for potential investors. While the iconic drug initially fueled enormous earnings, its protection has lapsed , leading to generic options flooding the market . This erosion in pricing presents a significant obstacle for copyright and any company considering a heavy stake in